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The orphan germinant receptor 
protein GerXAO (but not GerX3b) 
is essential for L-alanine induced 
germination in Clostridium 
botulinum Group II
Jason Brunt, Andrew T. Carter, Hannah V. Pye  & Michael W. Peck
Clostridium botulinum is an anaerobic spore forming bacterium that produces the potent botulinum 
neurotoxin that causes a severe and fatal neuro-paralytic disease of humans and animals (botulism). 
C. botulinum Group II is a psychrotrophic saccharolytic bacterium that forms spores of moderate 
heat resistance and is a particular hazard in minimally heated chilled foods. Spore germination is a 
fundamental process that allows the spore to transition to a vegetative cell and typically involves 
a germinant receptor (GR) that responds to environmental signals. Analysis of C. botulinum Group 
II genomes shows they contain a single GR cluster (gerX3b), and an additional single gerA subunit 
(gerXAO). Spores of C. botulinum Group II strain Eklund 17B germinated in response to the addition of 
L-alanine, but did not germinate following the addition of exogenous Ca2+-DPA. Insertional inactivation 
experiments in this strain unexpectedly revealed that the orphan GR GerXAO is essential for L-alanine 
stimulated germination. GerX3bA and GerX3bC affected the germination rate but were unable to 
induce germination in the absence of GerXAO. No role could be identified for GerX3bB. This is the first 
study to identify the functional germination receptor of C. botulinum Group II.
Clostridium botulinum is the name given to a heterogeneous species that comprises four distinct groups of bacte-
ria (C. botulinum Groups I to IV) that form the deadly botulinum neurotoxin1–5. The botulinum neurotoxin is the 
most potent toxin known, with a human lethal dose potentially being as little as 50 ng of neurotoxin2,5. There are a 
number of botulinum neurotoxin serotypes and subtypes6–11. Botulism in humans is most commonly associated 
with neurotoxin serotypes A, B or E, and more rarely with serotype F. There are three main types of human botu-
lism. Foodborne botulism is a severe intoxication caused by consumption of food containing neurotoxin formed 
by C. botulinum during its growth in the food, whilst infant and wound botulism are both infections involving 
growth and neurotoxin formation in the body1–5. C. botulinum Groups I to IV are sufficiently distinct as to be 
considered separate species, and two of these Groups (C. botulinum Groups I and II) are associated with human 
botulism cases.
C. botulinum Group I is a mesophilic highly proteolytic bacterium that forms exceptionally heat resistant 
spores that are the target of the botulinum cook (121 °C/3 min) given to low acid canned foods1–5. Strains form 
up to three neurotoxins of serotype A, B and/or F. C. sporogenes is a close relative of C. botulinum Group I, and is 
often used as a surrogate in food safety tests2,5,12. However, recent genomic analysis indicates that C. sporogenes 
is not simply a non-toxigenic version of C. botulinum Group I. A majority (but not all) strains of C. botulinum 
Group I form botulinum neurotoxin, and while a fraction of C. sporogenes strains form serotype B neurotoxin, 
the majority of C. sporogenes strains do not form botulinum neurotoxin8,13–16. C. botulinum Group II is a psy-
chrotrophic highly saccharolytic bacterium that forms spores of moderate heat resistance. Strains form a single 
neurotoxin of serotype B, E or F1–5. C. botulinum Group II is a concern for the continued safe production of mini-
mally heated chilled foods17–20. The genomic diversity within C. botulinum Group II is greater than that within C. 
botulinum Group I/C. sporogenes, and C. botulinum Group II strains separate into two distantly related lineages. 
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Lineage one contains the majority of serotype E strains, and these are strongly associated with the aquatic envi-
ronment. Lineage two is dominated by serotype B strains, and also contains serotype F and occasional serotype 
E strains, and these strains are more frequently linked with terrestrial ecosystems. Interestingly, physiological 
differences have been reported between strains in the two lineages5,8,21–30. Spores formed by C. botulinum Groups 
I and II are widely distributed in the environment, and the prevention of human botulism relies on the identifi-
cation and application of control measures that either prevent spores entering food or the body, or that prevent 
spore germination, cell multiplication and neurotoxin formation in food or the body. Spore germination is the 
key step in the transformation of the dormant resistant spore into multiplying vegetative cells that ultimately form 
botulinum neurotoxin. A greater understanding of spore germination can make an important contribution to 
microbiological food safety.
Spore germination has been widely studied in Bacillus species, and to a lesser extent in various species of 
Clostridium31–34. Spores germinate in response to nutrient germinants (e.g. amino acids) and to non-nutrient ger-
minants (e.g. Ca2+: pyridine-2, 6-dicarboxylic acid (Ca2+-DPA)). Under favourable conditions spore dormancy 
is broken and germination ensues. In the environment, spore germination is generally initiated by a germinant 
receptor (GR) located in the spore inner membrane that responds to a nutrient germinant35,36. Following this 
initial step, the large depot of Ca2+-DPA within the spore is released, peptidoglycan in the spore cortex is hydro-
lysed, and core swelling and hydration is then followed by cell outgrowth. However, in C. difficile and C. per-
fringens spore cortex hydrolysis precedes Ca2+-DPA release. This general pattern of germination is followed in 
most species, with some notable differences for example in the germinants and how they are sensed, and how the 
cortex peptidoglycan is hydrolysed. Genes encoding four types of GR (gerX1-4) and 12 GR sub-types (that were 
designated by an additional letter) have been identified in C. botulinum Groups I to IV37. Genes encoding puta-
tive GR are well conserved within each C. botulinum Group, and are generally composed of three protein units 
GerA, GerB, and GerC. The position is similar in most other spore-forming bacteria, with germination requiring 
all three protein units to be present34. The genomic and physiological differences between the four C. botulinum 
Groups is also reflected in their germination apparatus and germination pathways37. Despite the importance of C. 
botulinum Groups I and II to both the food and pharmaceutical industry, our current understanding of nutrient 
induced germination and the role of the GR is limited, but is presently better understood in strains of C. botuli-
num Group I (and C. sporogenes) than in strains of C. botulinum Group II37–39.
Spores of Group I and Group II strains germinate in response to a variety of amino acids interacting with a 
GR37,39–41. Analysis of genome sequences has revealed the presence of three to five GR gene clusters in strains of C. 
botulinum Group I/C. sporogenes37,39. Detailed analysis revealed that amino acid induced germination in C. botuli-
num Group I strain ATCC 3502 required two GR (GerX1a and GerX1d) that were only functional when acting in 
synergy, while a function could not be identified for a third GR (GerX2b)39. In contrast, amino acid induced spore 
germination in C. sporogenes strain ATCC 15579 needed only a single GR (GerX1d), with two other GR contrib-
uting to the germination rate (GerX2c and GerX3a), and a fourth GR (GerX1a) having no discernible function39. 
The genetic complement of GR genes in C. botulinum Group II, however, is very different. Analysis of more than 
150 C. botulinum Group II genome sequences has revealed the presence of only a single germinant receptor gene 
cluster (gerX3b) in each strain37,40. The gerX3b GR gene cluster has an unusual CA-B configuration that is different 
to the standard ABC configuration found in other C. botulinum Groups, as it has a bicistronic organization of 
gerAC and gerB genes orientated in opposite directions37,40. However, recently Clauwers et al. reported that this 
GR was not essential for amino acid induced spore germination in the C. botulinum Group II serotype E strain 
NCTC 1121940. Deletion of the gerX3b locus in this strain did not affect spore germination induced by a variety 
of amino acids, indicating that one or more unidentified GR are responsible for nutrient induced germination in 
strain NCTC 11219, and possibly also in other strains of C. botulinum Group II40. Strain NCTC 11219 belongs 
to C. botulinum Group II lineage one. The aim of the present study was to determine whether the GerX3b GR 
plays a major role in spore germination in strain Eklund 17B (that belongs to C. botulinum Group II lineage two) 
or whether the situation is similar to that reported by Clauwers et al.40 for strain NCTC 11219. We show that the 
GerX3b GR does not play a major role in spore germination in strain Eklund 17B, and have also identified a novel 
orphan germinant receptor, GerXAO, that is essential for amino acid induced germination.
Materials and Methods
Bacterial strains and growth conditions. C. botulinum Group II strain Eklund 17B (NRP) (serotype B) 
was grown anaerobically at 30 °C in tryptone-yeast-glucose medium (TYG). The Escherichia coli strain CA43442 
was used for conjugal transfer and grown aerobically in Luria-Bertani medium (LB) at 37 °C. Where appropri-
ate, growth media were supplemented with antibiotics at the following final concentrations; chloramphenicol 
25 µg/ml, cycloserine 250 µg/ml, thiamphenicol 15 µg/ml, erythromycin 5 µg/ml and the chromogenic substrate 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) 80 µg/ml. All bacterial media supplements were 
purchased from Sigma (Gillingham, UK). All culture and incubation experiments were performed in an anaero-
bic cabinet (Don Whitley, Shipley, UK) using an atmosphere of CO2: H2: N2 (5: 10: 85, v/v).
Comparative genomics and phylogenetic analysis. For identification of gerX genes in the genomes of 
C. botulinum Group II strains, genome sequences were re-annotated using Prokka version 1.1243. Roary version 
3.5.744 was used for comparative genomics. Alignments were made with Clustal omega45 and MEGA version 6.046 
and used for generation of phylogenetic trees using the Neighbour Joining option. Figtree47 was used for annota-
tion of phylogenetic trees. Conserved domains were identified using the Conserved Domain Database (NCBI)48.
Spore preparation. C. botulinum strain Eklund 17B was maintained as described previously41. Spores 
were produced on a biphasic cooked meat medium plate (CMP). Robertson’s cooked meat broth (CMB) (20 ml) 
(Southern Group Laboratories) was inoculated with 0.1 ml of culture (grown overnight in TYG broth at 30 °C) 
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and incubated for 24 h at 30 °C. CMP were prepared using homogenised CMB (200 ml) with 3 g of agar (Sigma) 
and 0.2 g of glucose (Fisher Scientific, UK). CMP were subsequently inoculated with 3 ml of the CMB culture and 
incubated at 30 °C for 7 days. Spores were harvested, cleaned, separated from cell debris by discontinuous density 
gradient (Urografin 370, Schering, Germany) centrifugation and stored at 2 °C in water, as described previously41. 
Phase contrast microscopy confirmed that the suspensions consisted of >95% phase-bright spores.
Mutant generation. Genes encoding presumptive germination receptor (GR) sub-units (gerX3bA, gerX3bB, 
gerX3bC) in C. botulinum strain Eklund 17B were identified previously37, and gerXAO was identified in the pres-
ent study. Mutants of C. botulinum strain Eklund 17B gerX3b subunits (gerX3bA; CB17B_RS15165, gerX3bB; 
CB17B_RS15170, gerX3bC; CB17B_RS15160, gerXAO; CB17B_RS12225) were generated using the Clostron sys-
tem as previously described39. Briefly, target sites were identified using the Perutka method49 and mutants were 
generated as described50. Re-targeted introns were synthesised and ligated into the pMTL007C-E2 vector by DNA 
2.0 (Menlo Park, USA). Retargeted intron plasmids were transformed into E. coli CA434. Confirmed (sequenced) 
plasmids were then transferred by conjugation into their respective clostridial host. For mutant complementa-
tion, plasmid pMTL83151 was used51. Primers bearing restriction sites compatible with pMTL83151 (BamHI 
and NheI) were used to amplify the gerX3b GR sub-units and its 5′ noncoding region, covering the predicted 
putative promoter. The resulting PCR product was digested with BamHI and NheI before being ligated into the 
pMTL83151 plasmid. Following confirmation by sequencing, complementation plasmids were transconjugated 
into their respective mutants using E. coli CA434 as described previously. Constructed mutants and plasmids uti-
lised in this study are presented in Table S1. Primers used for verification of successful insertion events are listed 
in Table S2. PCR experiments were carried out using Phusion High-Fidelity PCR Master Mix with GC Buffer kit 
(Thermo Fisher). Plasmid isolation and PCR purification was performed using the Wizard Plus SV Minipreps 
DNA Purification System and the Wizard SV Gel and PCR Clean-Up System (Promega) respectively, as described 
in the provided Technical Manual. Chromosomal DNA isolation from suspected mutants were prepared as pre-
viously described52.
Spore germination. The germinant L-alanine (50 mM) (Sigma) was prepared in phosphate buffer (100 mM, 
pH 7.0) with NaHCO3 (50 mM) and L-lactate (50 mM). Germinant solutions were filter sterilised (0.45-µm 
syringe filter, Millipore, Bedford, MA, USA) and used within 1 h. Spore germination was also evaluated using 
Ca2+-DPA (60 mM, pH 7.4) in 20 mM Tris-HCl (pH 7.4) and NaHCO3 (50 mM). All spore suspensions were 
heat activated at 60 °C for 15 min, prior to the addition of potential germinants. Germination of spores at 30 °C 
was measured by a decrease in optical density (OD) at 600 nm every 5 min using a Bioscreen C analyser sys-
tem (Labsystems, Basingstoke, UK). All germination experiments were performed in an anaerobic cabinet (Don 
Whitley) containing CO2: H2: N2 (5: 10: 85). Germination was expressed in terms of measured OD600 as a percent-
age of the initial OD600. To validate the OD600 measurements the proportion of germinated spores was visualised 
by the assessment of 200 spores in at least ten fields using phase-contrast microscopy. Typically, full germination 
was indicated when the OD600 fell to ~50–60% of its initial value. In some tests, a small fall in OD600 was observed 
(<10% of initial value). This was attributed to settling of spores in the Bioscreen wells, and was not accompanied 
by microscopic observation of spore germination. All experiments were performed in triplicate and the standard 
deviation calculated from three independent experiments. Statistical analysis of germination was completed using 
the two-tailed Student’s T-test with a significance level of 0.05.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Results and Discussion
The effect of two potential germinants, L-alanine and exogenous Ca2+-DPA, on the germination of C. botulinum 
strain Eklund 17B spores was evaluated (Fig. 1). In the presence of L-lactate (50 mM) and NaHCO3 (50 mM) 
at 30 °C, the addition at 50 mM of L-alanine initiated spore germination, as observed by a > 50% drop of initial 
OD600, after approximately 30 min (Fig. 1). Direct spore counts by phase contrast microscopy revealed a ~50% 
drop in OD600 correlated to >99% spore germination. Similarly, amino acid induced spore germination of other 
C. botulinum Group II strains has been previously reported40,41. As previously described, L-lactate was an essen-
tial co-germinant for L-alanine germination but did not stimulate germination on its own41. Similarly, although 
experiments were performed under anaerobic conditions, this was considered non-essential41. The mode of 
action of L-lactate on spore germination is unknown, but may include one of the following; (1) L-alanine and 
L-lactate interact before interacting with the GR, (2) L-lactate may directly affect the GR together or sequentially 
with L-alanine or (3) L-lactate affects yet unidentified proteins that are part of the germination pathway. The 
GR-independent germinant Ca2+-DPA (60 mM) is a non-nutrient germinant of some Clostridium and Bacillus 
species34, including C. sporogenes and C. perfringens47,53,54. However, exogenous Ca2+-DPA failed to induce spore 
germination in C. botulinum Eklund 17B, as determined by optical density measurement and phase contrast 
microscopy (Fig. 1). This observation is consistent with that made in a recent study with C. botulinum Group II 
strain NCTC 11219 where exogenous Ca2+-DPA also failed to induce spore germination40. Spores of strains in 
both C. botulinum Group II lineage one (strain NCTC 11219) and in lineage two (strain Eklund 17B) are there-
fore not germinated by exogenous Ca2+-DPA. It would be interesting to test the effect of exogenous Ca2+-DPA on 
strains in all four C. botulinum Groups. Spores of Clostridium and Bacillus species both contain a large amount of 
a 1:1 chelate of Ca2+ and pyridine-2, 6-dicarboxylic acid (DPA) within their core. In Bacillus and C. sporogenes, 
exogenous Ca2+-DPA activates the cortex lytic enzyme CwlJ to trigger spore germination47,54, whereas in C. per-
fringens Ca2+-DPA triggers germination through the GerK GR53. The failure of exogenous Ca2+-DPA to induce 
C. botulinum Eklund 17B spore germination in the present study (and strain NCTC 11219 previously) could be 
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due to the absence of CwlJ, as there are no genes encoding CwlJ homologs in C. botulinum Group II genomes37. 
Moreover, C. botulinum Group II genomes do not contain the cortex lytic enzyme SleB found in most Bacillus 
and clostridia34 but instead possess the cortex lytic enzyme SleC as a zymogen. As with C. botulinum Eklund 17B, 
C. difficile spores do not germinate with the addition of Ca2+-DPA55, and their genomes lack genes encoding a 
homolog of CwlJ and also a ‘classical’ nutrient GR55,56 although they do possess a SleC similarly to C. botulinum 
Group II strains.
In most species, spore germination is initiated by a germinant receptor (GR) located in the spore inner mem-
brane. The C. botulinum Eklund 17B genome includes a gerX3b (gerX3bA, gerX3bB, gerX3bC) receptor (Fig. 2a,b), 
similar to those described in other C. botulinum Group II strains37,40. Based on the sequence of the entire ger-
minant receptor cluster, strains of C. botulinum Group II can be separated into two clades (Fig. 2a) that directly 
align with the two lineages derived from whole genome analysis8,28. The gerX3b germinant receptor in strain 
Eklund 17B is located in clade two in Fig. 2a (while the gerX3b germinant receptor in strain NCTC 11219 studied 
by Clauwers40 is found in clade one). Clade one exclusively contains strains forming type E neurotoxin, while 
Figure 1. Effect of L-alanine (50 mM) and exogenous Ca2+-DPA (60 mM) on germination of C. botulinum 
Eklund 17B wild type spores. Data labels (right) refer to percentage germination observed by phase contrast 
microscopy at 3 hours. Error bars represent the standard deviation of 3 independent experiments.
Figure 2. Relatedness of GerX3b receptor gene clusters in Clostridium botulinum Group II and genetic 
organization of the gerX subtypes. (a) Relatedness of gerX3b types in C. botulinum Group II (toxin types shown 
in coloured boxes). gerX associated proteins used for comparisons; gerX3bA (Locus tag; CB17B_RS15165), 
gerX3bB (Locus tag; CB17B_RS15170), gerX3bC (Locus tag; CB17B_RS15160) and gerXAO (Locus tag; 
CB17B_RS12225). *Represents strain C. botulinum Eklund 17B (NRP) (Accession number; FR745875) 
used in this study. †Represents strain C. botulinum NCTC 11219 for comparison. Clade I consist of strains 
forming neurotoxin type E, and Clade II includes strains forming type neurotoxin types B, E or F. Strains 
used for comparison of the gerX3b types see Brunt et al.37. The phylogenetic tree is based on single nucleotide 
polymorphisms (SNPs). Values shown at branches represent bootstrap values provided by ParSNP. (b) 
Genetic organization of the gerX3b gene cluster. (c) gerXAO is flanked by asparagine synthetase (asnB) and an 
uncharacterized S1 RNA binding domain protein (yitL).
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clade two comprises strains forming type B, E or F neurotoxin (Fig. 2a). The gerX3b receptor gene cluster has a 
bicistronic organization, with gerAC and gerB genes being orientated in the opposite direction (CA-B configu-
ration) (Fig. 2b). Analysis of more than 150 C. botulinum Group II genome sequences also revealed the presence 
of a single gerA subunit (termed here gerXAO, Fig. 2c) in each strain, indicating its likely importance. This single 
gerA subunit was distantly located on the chromosome from the gerX3b receptor gene cluster. The gerXAO gene, 
in general, is flanked by an asparagine synthetase (asnB) and an uncharacterized S1 RNA binding domain (yitL) 
gene. The annotation of this single gerA subunit is somewhat inconsistent with annotations frequently describing 
it as encoding a germination protein (GerA spore germination protein), or more rarely a sporulation protein 
(Stage V sporulation protein AF (SpoVAF)). However, Conserved Domain analysis confirmed that the GerXAO 
protein belongs to the GerA superfamily (cl10605). BlastP analysis also revealed high similarity between orphan 
GerA gene products from C. botulinum Group II strains (90–100%) and those identified by sequence similarity as 
spore germination proteins from C. perfringens and C. taenosporium (61% and 90% respectively). These are also 
not associated with either an ABC- or CA-B-type cluster structure. Interestingly, peptide sequence alignment of 
the GerXAO gene product with the receptor-associated (CA-B) GerA revealed only ~27% similarity at the amino 
acid level.
To characterise the functionality of the putative GR encoded by gerX3b (gerX3bA, gerX3bB, gerX3bC) in 
C. botulinum Eklund 17B, single insertional mutants of each gene were generated and confirmed by PCR and 
sequencing (Fig. 3). However, it should be noted that given the absence of formal characterisation of any C. 
botulinum gene promoters, mutation of gerX3bA may have a polar effect on gerX3bC. Mutation of C. botulinum 
Group II is challenging40, and several attempts were needed to isolate mutants for this strain. Spores generated 
from these mutants were analysed for L-alanine induced germination (Fig. 4). Mutants gerX3bA− and gerX3bC− 
failed to germinate (<10% fall in OD600) with L-alanine after 1 h of exposure (Fig. 4a). However, gerX3bC− spores 
started to germinate slowly after 1 h (as determined by a fall in OD600). The OD600 of wild type spores decreased 
(∼50%) after ~30 min, representing efficient and complete spore germination (≥99%) as observed by phase con-
trast microscopy. Interestingly, the gerX3bB− mutant exhibited comparable germination profiles to those of wild 
type spores indicating a lack of function in this stage of the germination process. This is in contrast to GerKB in 
C. perfringens, which is involved in spore viability and outgrowth57. The lack of phenotype for the Eklund 17B 
gerX3bB− mutant is also surprising as the GerB protein in Bacillus is proposed to be responsible for germinant 
binding and influencing the GerC protein58–60. This apparent lack of function is additionally unexpected when 
the abundance of monocistronic gerB genes is considered, especially in the knowledge that C. botulinum Group 
II genomes are relatively stable with the potential for horizontal gene transfer considered low8,28. Further work is 
required, including examination of the orphan monocistronic gerB genes in C. botulinum Group I.
Phase contrast microscopy was used to determine the percentage of spores that had germinated (i.e. become 
phase dark) after 3 h and 24 h at 30 °C (Fig. 4b,c). Incubation with L-alanine for 3 h, resulted in negligible 
Figure 3. Confirmation of insertional mutagenesis. (a) PCR screens of C. botulinum gerX gene mutants 
confirming that the intron has successfully inserted into the target gene. Numbers represent primer sets used. 
Gel image has been cropped, full image available in supplementary figure (S1). (b) C. botulinum germination 
genes showing Clostron insertion sites (red arrows). Black arrows represent primer annealing sites. Primer set 
1 (gerC-F/R) anneals to the target gene CB17B_RS15160 gerX3bC either side of the intron insertion site and 
confirms the intron is present in the target gene (expected band size of mutants ~2 kb). Primer set 2 (gerAB-F/R) 
anneals to the target gene CB17B_RS15165 gerX3bA and CB17B_RS15170 gerX3bB either side of the intron 
insertion sites and confirms the intron is present in the target gene. Primer set 3 (gerAO-F3/R3) anneals to the 
target gene CB17B_RS12225 gerXOA either side of the intron insertion sites and confirms the intron is present 
in the target gene.
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germination of mutant gerX3bA− and limited germination of mutant gerX3bC−, but complete germination of 
the wild type and gerX3bB− (Fig. 4b). Following incubation with L-alanine for 24 h, mutants gerX3bA− and 
gerX3bC− displayed germination approaching that of the wild type and gerX3bB− (Fig. 4c). Complementation of 
gerX3bA− and gerX3bB− using plasmid pMTL83151 containing the gerX3b GR sub-units and their 5′ noncoding 
region restored the germination phenotype of gerX3bA− and did not alter the wild type phenotype of gerX3bB−. 
Albeit, the rates of germination of these complemented mutants were not fully restored compared to that of the 
wild type (Fig. 4d). Complementation of gerX3bC− did not restore the germination rate phenotype; this lack 
of successful complementation has been observed for many generated mutants in clostridia, but the reason is 
unclear37,39,61,62. However, in the absence of formal characterisation of any C. botulinum gene promoters, apart 
from BotR regulated ones in the neurotoxin gene cluster, we predicted that the promoter to be located in the inter-
genic region upstream of the gerX3bA gene and therefore the complementation of gerX3bC− may have failed due 
to the lack of a native promoter. Furthermore, attempts at expressing the whole receptor failed so complementa-
tion of gerX3bC− strain could not be assessed. The configuration of the bicistronic divergent gerCA and gerB gene 
cluster found in all C. botulinum Group II strains is comparable to the gerK locus reported in C. perfringens which 
comprises of a bicistronic gerKA-gerKC and monocistronic gerKB in the opposite orientation53,63. The similarity 
of the GR amino acid sequences for C. perfringens SM101 is approximately GerKA 63%, GerKB 36% and GerKC 
46% when compared to those of C. botulinum Eklund 17B GerX3bA, GerX3bB, and GerX3bC, respectively. In C. 
perfringens, the GerKC protein is considered to be the main GR with GerAA and GerKB proteins playing a minor 
role in spore germination53,63. However, a recent report has now demonstrated that in the C. botulinum Group 
II strain NCTC 11219 GerX3b was not required for nutrient induced germination40. In this work, the entire 
GR cluster was deleted, and germination was similar in the wild type and mutant after 4 h/30 °C, as measured 
by number of heat resistant spores and DPA loss. Phase contrast microscopy additionally revealed that the rate 
of formation of phase dark spores was similar and virtually complete after 1 h/30 °C40. The findings made in the 
present study with strain Eklund 17B are consistent with the observation made with strain NCTC 11219 that the 
GerX3b receptor is not essential for spore germination in strains of C. botulinum Group II, and importantly now 
extend the finding to both major C. botulinum Group II lineages. We also demonstrate, for the first time, that in 
strain Eklund 17B two of the GR receptor proteins contribute to the germination rate and in their absence the 
germination rate is much slower with L-alanine compared to the wild type. The presence of gerX3b in the genome 
Figure 4. Effect of L-alanine (50 mM) on spore Germination of C. botulinum Eklund 17B gerX3bA−, 
gerX3bB−, gerX3bC−, gerXAO− and wild type. (a) Kinetics of spore germination determined using fall in 
OD600. (b) Spore germination after 3 hours (percentage of phase dark spores as determined by phase contrast 
microscopy). (c) Spore germination after 24 hours (percentage of phase dark spores as determined by phase 
contrast microscopy). (d) Kinetics of spore germination of the complemented mutants determined using fall in 
OD600. Error bars represent the standard deviation of three independent experiments. *Student’s T-test with a 
significance level of 0.05. **Not significant at level of 0.05 compared to the wild type. +complemented strains.
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of all C. botulinum Group II strains examined to date37,40 indicates that the product of this gene cluster is likely 
to have an important biological role, for example it may respond to an as yet unknown nutrient/non-nutrient 
germinants, or perform a structural role for instance in the organisation of a germinosome64.
Given the findings presented here and those made by Clauwers et al.40 that the GerX3b receptor does not play 
a major role in spore germination in C. botulinum Group II, functional GR were now sought, and the potential 
role of GerXAO was assessed. Following insertional mutagenesis, spores were produced, and tested for L-alanine 
induced germination. Mutant gerXAO− failed to germinate (<10% fall in OD600) with more than 99% of spores 
appearing phase bright after incubation for 24 h (Fig. 4). Additionally, complementation of gerXAO− using plas-
mid pMTL83151 restored germination to similar levels of the wild type (≥99%). Thus, GerXAO plays a major 
role in spore germination in Eklund 17B.
An orphan gerA gene is located in the genome of several species of Clostridium32,65, and is present in the 
genome of all of more than 150 strains of C. botulinum Group II examined in the present study, which indicates 
there is an evolutionary advantage to its retention as a functional gene. However, the orphan GerA present in C. 
perfringens played only a minor role in germination53. Tentative evidence in this study also revealed that spor-
ulation efficiency appeared to be affected by mutation of gerXAO, as determined by phase contrast microscopy. 
Again, the reasons for this are unclear, we can only speculate that the loss of this receptor protein has an effect on 
an as yet unknown protein or signal that is involved in sporulation. Although this is the first report of an essential 
requirement for a monocistronic GerA in spore germination, function has been attributed to a monocistronic 
GerB which is involved in germinant specificity and rate in spores of Bacillus megaterium QM B155166. Moreover, 
this GerB receptor subunit interacts with GerUA and GerUC to form a functional receptor. In C. botulinum 
Group II strain Eklund 17B, the rate of spore germination is more rapid when GerXAO interacts with GerX3bA 
and/or GerX3bC, than when either GerX3bA or GerX3bC are absent. However, further work is certainly war-
ranted to understand the exact mechanism of the GerXAO receptor and to whether it responds to further ger-
minants. Interestingly, the position in C. botulinum Group II strain Eklund 17B, where GerXAO brings about 
germination on its own with other proteins (GerX3bA and/or GerX3bC) increasing the rate, contrasts with the 
situation in most other spore-forming bacteria where germination involves a GR with three protein units (GerA, 
GerB, and GerC). A potential role for presently unidentified proteins that interact with GerXAO to bring about 
germination cannot also be excluded. Following the results presented here we now propose an updated version37 
of the germination model for C. botulinum Group II strains (Fig. 5). Firstly, the nutrient germinant binds to the 
GerXAO receptor, followed by Ca2+-DPA release through the SpoVA channel (Stage I). In stage II, the cortex lytic 
Figure 5. Comparison of the models proposed for the germination pathways of C. botulinum Group I and 
Group II. (a) Group II, with GerXAO (shaded grey) as the major germinant receptor and GerX3bA & GerX3bC 
(shaded green) involved in germination rate. Initially, L-alanine binds to the GerXAO receptor, followed by 
Ca2+-DPA release through the SpoVA channel (Stage I). In stage II, the cortex lytic enzyme SleC is activated 
by CspB, followed by cortex hydrolysis, membrane, and coat degradation, the resumption of metabolism and 
ultimately cell outgrowth. *Cortex lytic enzymes include SleC2 a/b and SleB2. (b) Germination pathway for C. 
botulinum strain ATCC3502 (Group I)37,39. This system involves the recognition of nutrient germinants by their 
cognate receptor GerX1a &GerX1d acting together, followed by Ca2+-DPA release through the proposed SpoVA 
channel (Stage I). In stage II, the CLEs CwlJ and SleB (†) are activated, followed by cortex hydrolysis, membrane 
and coat degradation, the recommencement of metabolism and eventually cell outgrowth. “?” indicates that 
the timing of the release of Ca2+-DPA is presently unknown in C. botulinum Group I and Group II and may be 
released following germinant binding or after cortex hydrolysis.
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enzyme SleC is activated by CspB, followed by cortex hydrolysis, membrane and coat degradation, the resump-
tion of metabolism and ultimately cell outgrowth. Although, the order of these events still needs to be resolved in 
C. botulinum group II strains (Fig. 5)
In summary, this is the first report that successfully identifies the key component of the germination machin-
ery of C. botulinum Group II strain Eklund 17B. The presence of the orphan gene encoding GerXAO in all C. 
botulinum Group II genomes so far examined strongly suggests that the germination model proposed in this work 
will stand for all Group II strains. The role of GerX3bB, a gene equally conserved but with no obvious function, 
remains un-resolved. However, it is clear that gene products of its neighbouring operon interact with that of 
gerXAO to increase the efficiency of the germination process.
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